Polyphron builds an autonomous tissue foundry platform for scalable, reproducible human tissue manufacturing.
Polyphron has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Polyphron's investors include Quiet Capital, Gradient, Haystack, Compound, Pareto Holdings.
Polyphron is headquartered in New City, United States.
Polyphron builds an autonomous tissue foundry platform for scalable, reproducible human tissue manufacturing.
Polyphron is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Polyphron — Funding & Investors." VCBacked, September 17, 2026, https://www.vcbacked.co/company/polyphron. Accessed October 1, 2026.
VCBacked. (2026). Polyphron — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/polyphron
{{cite web |title=Polyphron — Funding & Investors |url=https://www.vcbacked.co/company/polyphron |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated